الفهرس | Only 14 pages are availabe for public view |
Abstract AKI is a widespread and dangerous issue that affects millions and leaves many people dead or disabled. It is characterized by a sudden decline in renal function that causes an accumulation of nitrogenous waste products and, frequently, a decrease in urine output. COVID-19 is an infectious disease caused by (SARS-CoV-2 virus). Most individuals affected with the virus will have mild to moderate respiratory symptoms and recover without the need for special treatment. Nevertheless, some people will become seriously ill and require medical care. Despite receiving little attention, AKI is one of the most significant COVID-19 consequences. Numerous studies have examined the incidence of AKI among COVID-19 patients in various contexts. However, understanding of AKI risk factors and outcomes are not completely focused on in the literature, especially in Egypt. The main goal of this study is, evaluating the incidence of AKI in COVID-19 patients, showing the most common outcomes, and shedding the light on the associated risk factors. This study is a retrospective observational study conducted on 296 patients in Isolation unit in Suez Canal University Hospital, Ismailia governorate, Egypt, in the period between Feb 1, 2022, and Aug 1, 2022. Additionally, Patients, who were included; had a COVID-19 infection confirmed by a positive PCR test, who are 18 years of age or older, admitted to Suez Canal University Hospital, and are willing to accept to be interviewed throughout the study. Collected data included the following: • Sociodemographic characteristics (age, gender, and chronic illnesses). • Cardiorespiratory parameters (oxygen saturation on room air, oxygen supply need, need for MV in ICU patients, and use of cardiac support). • Baseline investigations (total leucocytic count, lymphocytic count, NLR, serum Na+, serum K+, preexisting baseline SCr, and preexisting eGFR). Chapter 6: Summary |